{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n In soft‐tissue sarcoma, BACH1‑IT2 is one of a ten‐lncRNA prognostic signature identified through high‐throughput RNA‐seq analysis of TCGA data that correlates with overall patient survival (1). Although its precise biological role remains to be fully elucidated, BACH1‑IT2 contributes to a composite risk score that is significantly associated with key clinical parameters—including the mitotic count of tumor cells, neoplastic status, and presence of residual tumor—thereby serving as an independent indicator of clinical outcome. This signature, which integrates BACH1‑IT2 among the panel of prognostic lncRNAs, underscores its potential utility in prognostic stratification and outcome prediction for patients with soft‐tissue sarcoma (1)."}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Rong-Quan He, Qing-Jun Wei, Rui-Xue Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.18165"}], "href": "https://doi.org/10.18632/oncotarget.18165"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29113307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29113307"}]}]}]}